Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis

A Study to evaluate efficacy and safety in subjects with moderate to severe Plaque Psoriasis treated with a TYK2 Inhibitor for 12 weeks

Participants needed: 140
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: Usynova Pharmaceuticals Ltd.Updated: Nov 18, 2025Locations: 1
Eligibility criteria

Male and female, ages 18 to 70 years [+3]

Diagnosed with non-plaque psoriasis [+6]

Status: Recruiting

A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis

This study is a randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetic profile, and food effect of UA026 tablets. The study consists of four parts: Part A is a single ascending dose (SAD) study, Part B is a multiple ascending dose (MAD) study, Part C is a food effect (FE) study, and Part D is a multi-dose parallel control study. Part A, B, and C will be conducted in healthy subject, and Part D will be conducted in subjects with moderate to severe plaque psoriasis.

Participants needed: 124
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Usynova Pharmaceuticals Ltd.Updated: Nov 17, 2025Locations: 1
Eligibility criteria

Men and women aged 18-55 at the time of screening visit; [+6]

Allergy to the investigational drugs or the excipients, or a history of severe a... [+76]